Delivery Order SPE2DB20D3101-SPE2DB25FRQB5
Award Date 7/14/25
Potential Completion Date 8/4/25
Potential Value $4.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,753.28 to AmerisourceBergen Drug Corp for the supply of Xolair 300 mg/2 mL auto-injectors. This firm fixed-price, non-set-aside contract is scheduled for completion by August 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,941.60 on July 23, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania, the company's headquarters. The delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $28,694.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Xolair 300 mg/2 ml auto-injectors. This non-set-aside contract, issued on July 31, 2025, requires completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $76,519.68 to AmerisourceBergen Drug Corp for Xolair 300 mg/2 mL auto-injector units. The contract was competitively awarded on July 21, 2025, with a firm fixed price structure and an ultimate completion date of August 11, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xolair 300 mg/2 ml auto-injector units, with a contract value of $1,594.16 and an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded delivery order operates under firm fixed pricing and is being performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xolair 300 mg/2 mL auto-injectors with a ceiling value of $3,188.32. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,970.80 to AmerisourceBergen Drug Corp for Xolair 300 mg/2 ml auto-injector medication, with an ultimate completion date of August 18, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,782.48 on August 8, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 29, 2025, with fulfillment occurring at the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $6,376.64 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 22, 2025. The award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials, valued at $6,376.64 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 13, 2025, and fulfillment is to occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...